Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Jun;72(3):213–216. doi: 10.1136/sti.72.3.213

Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.

O K Ndimbie 1, L A Kingsley 1, S Nedjar 1, C R Rinaldo 1
PMCID: PMC1195654  PMID: 8707327

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of morbidity throughout the world. Parenteral exposure to infected blood accounts for the majority of cases. Sexual transmission is suggested by the higher prevalence of infection in sex workers and homosexual men. Sexual practices which contribute to HCV infection need to be identified. METHODS: The social and medical history, and HCV serostatus of 1058 homosexual men in the Pittsburgh arm of the Multicenter AIDS Cohort Study were analysed. Multivariate analysis was used to determine risk factors for HCV seropositivity. RESULTS: 31 men were HCV seropositive by enzyme immunoassay and recombinant immunoblot assay (2.9%). They were more likely to be HIV seropositive (39%) than the HCV seronegative men (19%). Needle sharing and illegal drug use were the most important risk factors for HCV seropositivity. Statistically significant sexual factors (p < 0.05) included a history of syphilis, rectal gonorrhea, anal insertive intercourse with ejaculation, and douche or enema use before anal receptive intercourse. The number of sexual partners was not a significant risk factor. CONCLUSIONS: HCV infection is associated with specific sexually transmitted diseases (STDs) and sexual practices in the male homosexual population. The evidence of high risk behavior should be incorporated into ongoing educational efforts to decrease the incidence of STDs.

Full text

PDF
213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A., Chemello L., Cavalletto D., Tagger A., Dal Canton A., Bizzaro N., Tagariello G., Ruol A. Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med. 1991 Jun 15;114(12):1010–1012. doi: 10.7326/0003-4819-114-12-1010. [DOI] [PubMed] [Google Scholar]
  2. Alonso C., Pedroso M. L., de Sanjosé S., Montcharmont P., Chèvre J. M., Boucaud M. J., Lambert V., Cortey M. L., Trépo C. Hepatitis C virus among blood donors: follow-up study. Transfusion. 1994 Jun;34(6):527–530. doi: 10.1046/j.1537-2995.1994.34694295070.x. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990 Nov 7;264(17):2231–2235. [PubMed] [Google Scholar]
  4. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  5. Bresters D., Mauser-Bunschoten E. P., Reesink H. W., Roosendaal G., van der Poel C. L., Chamuleau R. A., Jansen P. L., Weegink C. J., Cuypers H. T., Lelie P. N. Sexual transmission of hepatitis C virus. Lancet. 1993 Jul 24;342(8865):210–211. doi: 10.1016/0140-6736(93)92300-i. [DOI] [PubMed] [Google Scholar]
  6. Donahue J. G., Nelson K. E., Muñoz A., Vlahov D., Rennie L. L., Taylor E. L., Saah A. J., Cohn S., Odaka N. J., Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991 Nov 15;134(10):1206–1211. doi: 10.1093/oxfordjournals.aje.a116023. [DOI] [PubMed] [Google Scholar]
  7. Dubin G., Braffman M. N. Zidovudine-induced hepatotoxicity. Ann Intern Med. 1989 Jan 1;110(1):85–86. doi: 10.7326/0003-4819-110-1-85. [DOI] [PubMed] [Google Scholar]
  8. Eyster M. E., Diamondstone L. S., Lien J. M., Ehmann W. C., Quan S., Goedert J. J. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1993 Jun;6(6):602–610. [PubMed] [Google Scholar]
  9. François M., Dubois F., Brand D., Bacq Y., Guerois C., Mouchet C., Tichet J., Goudeau A., Barin F. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol. 1993 May;31(5):1189–1193. doi: 10.1128/jcm.31.5.1189-1193.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fried M. W., Shindo M., Fong T. L., Fox P. C., Hoofnagle J. H., Di Bisceglie A. M. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology. 1992 Apr;102(4 Pt 1):1306–1308. [PubMed] [Google Scholar]
  11. Garson J. A., Clewley J. P., Simmonds P., Zhang L. Q., Mori J., Ring C., Follett E. A., Dow B. C., Martin S., Gunson H. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang. 1992;62(4):218–223. doi: 10.1111/j.1423-0410.1992.tb01202.x. [DOI] [PubMed] [Google Scholar]
  12. Gradon J. D., Chapnick E. K., Sepkowitz D. V. Zidovudine-induced hepatitis. J Intern Med. 1992 Mar;231(3):317–318. doi: 10.1111/j.1365-2796.1992.tb00542.x. [DOI] [PubMed] [Google Scholar]
  13. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  14. Kaslow R. A., Phair J. P., Friedman H. B., Lyter D., Solomon R. E., Dudley J., Polk B. F., Blackwelder W. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Ann Intern Med. 1987 Oct;107(4):474–480. doi: 10.7326/0003-4819-107-4-474. [DOI] [PubMed] [Google Scholar]
  15. Kihara M., Imai M., Kondoh M., Watanabe S., Kihara M., Soda K. [Prevalence of hepatitis C virus and human immunodeficiency virus infection among Japanese female prostitutes]. Nihon Koshu Eisei Zasshi. 1993 May;40(5):387–391. [PubMed] [Google Scholar]
  16. Kiyosawa K., Tanaka E., Sodeyama T., Furuta K., Usuda S., Yousuf M., Furuta S. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Jpn J Cancer Res. 1990 Nov;81(11):1089–1091. doi: 10.1111/j.1349-7006.1990.tb02517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Martin P., Di Bisceglie A. M., Kassianides C., Lisker-Melman M., Hoofnagle J. H. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989 Dec;97(6):1559–1561. doi: 10.1016/0016-5085(89)90405-8. [DOI] [PubMed] [Google Scholar]
  18. McOmish F., Yap P. L., Dow B. C., Follett E. A., Seed C., Keller A. J., Cobain T. J., Krusius T., Kolho E., Naukkarinen R. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994 Apr;32(4):884–892. doi: 10.1128/jcm.32.4.884-892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Melbye M., Biggar R. J., Wantzin P., Krogsgaard K., Ebbesen P., Becker N. G. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ. 1990 Jul 28;301(6745):210–212. doi: 10.1136/bmj.301.6745.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Meyer R. A., Gordon S. C. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol. 1991 Sep;86(9):1224–1226. [PubMed] [Google Scholar]
  21. Mihaljević I., Feldbauer J., Delajlija M., Grgicević D. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients. Vox Sang. 1992;63(3):236–236. doi: 10.1111/j.1423-0410.1992.tb05109.x. [DOI] [PubMed] [Google Scholar]
  22. Nishiguchi S., Kuroki T., Fukuda K., Nakajima S., Shiomi S., Murata R., Isshiki G., Kobayashi K. Familial clustering of HCV. Lancet. 1992 Jun 13;339(8807):1486–1486. doi: 10.1016/0140-6736(92)92088-w. [DOI] [PubMed] [Google Scholar]
  23. Osmond D. H., Charlebois E., Sheppard H. W., Page K., Winkelstein W., Moss A. R., Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan;167(1):66–71. doi: 10.1093/infdis/167.1.66. [DOI] [PubMed] [Google Scholar]
  24. Ragni M. V., Ndimbie O. K., Rice E. O., Bontempo F. A., Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion". Blood. 1993 Aug 1;82(3):1010–1015. [PubMed] [Google Scholar]
  25. Rivero R. A., Hedalgo-Gato R., Martinez M., Hernandez P., Ballester J. M., Yamaguchi K., Fukuyoshi Y., Kiyokawa T., Takatsuki K. Antibodies to hepatitis C virus in Cuban blood donors. Vox Sang. 1992;63(4):285–286. doi: 10.1111/j.1423-0410.1992.tb01238.x. [DOI] [PubMed] [Google Scholar]
  26. Robson S. C., du Toit J. M., Brice E. A., Bird A. R., Brink N. S. Hepatitis C virus antibodies in patients with liver disease. The western Cape experience. S Afr Med J. 1991 Sep 21;80(6):282–284. [PubMed] [Google Scholar]
  27. Tibbs C. J., Palmer S. J., Coker R., Clark S. K., Parsons G. M., Hojvat S., Peterson D., Banatvala J. E. Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays. J Med Virol. 1991 Jul;34(3):143–147. doi: 10.1002/jmv.1890340302. [DOI] [PubMed] [Google Scholar]
  28. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]
  29. Wang J. T., Wang T. H., Sheu J. C., Tsai S. J., Hsieh Y. S., Lin D. T., Wang C. Y., Chen D. S. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Arch Pathol Lab Med. 1993 Feb;117(2):152–156. [PubMed] [Google Scholar]
  30. Zhang H. Y., Kuramoto I. K., Mamish D., Sazama K., Holland P. V., Zeldis J. B. Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol. 1993 Mar;31(3):606–609. doi: 10.1128/jcm.31.3.606-609.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. al-Nakib B., Koshy A., Kaloui M., al-Ramahi S., al-Mufti S., Radhakrishnan S., al-Nakib W. Hepatitis C virus antibody in Kuwait. Vox Sang. 1992;63(1):75–76. doi: 10.1111/j.1423-0410.1992.tb01224.x. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES